BioSpace News Archive

Policy

International Patent Application Filed for Cervical Cancer Vaccine

BioVaxys Technology Corp.,, announced that it has continued to expand the patent coverage for its cancer vaccine platform by filing an international patent application through the Patent Cooperation Treaty for broad geographic market coverage outside the US for cervical cancer.

May 2, 2022
·
5 min read
FDA

Limaca Medical Receives FDA Breakthrough Device Designation

Limaca Medical ( “Limaca” ) announced today that its Precision-GI™ Endoscopic Ultrasound Biopsy Product has received a Breakthrough Device Designation from the U.S. Food and Drug Administration ( “FDA” ).

May 2, 2022
·
4 min read
Drug Development

ALTAVANT SCIENCES PRESENTED DATA AT ISHLT SHOWING POTENCY AND DISTRIBUTION OF BRONCHIOLITIS OBLITERANS CANDIDATE, ALTA-2530

Altavant Sciences announced today that the company made an oral presentation of preclinical results supporting the development of ALTA-2530 for the treatment of bronchiolitis obliterans syndrome.

May 2, 2022
·
4 min read
Pharm Country

Idorsia’s new treatment QUVIVIQ (daridorexant) is now available in the US for adults living with insomnia

Idorsia Ltd (SIX: IDIA) & Idorsia Pharmaceuticals, US Inc. today announced that QUVIVIQ™ (daridorexant) CIV 25 mg and 50 mg tablets are now commercially available for adult patients with insomnia, which is characterized by trouble with falling or staying asleep.

May 2, 2022
·
9 min read
Biotech Beach

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Aethlon Medical, Inc. (Nasdaq: AEMD), today announced the publication of a pre-print manuscript featuring data that demonstrated Aethlon’s proprietary GNA affinity resin was able to bind seven clinically relevant SARS-CoV-2 variants in vitro, including the Delta and Omicron variants.

May 2, 2022
·
6 min read
Business

Natera Announces First Quarter 2022 Earnings Conference Call

Natera, Inc. today announced that it will release results for its first quarter ended March 31, 2022, after the market close on May 5, 2022.

May 2, 2022
·
1 min read
Policy

Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute

Teva Announces Settlement with Lupin Resolving AUSTEDO ® (deutetrabenazine) Patent Dispute.

May 2, 2022
·
8 min read
Business

ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022

ENDRA Life Sciences Inc. today announced that the company will report financial results for the first quarter of 2022 on Thursday, May 12, 2022 after the close of trading on the U.S. financial markets.

May 2, 2022
·
2 min read
Business

LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022

LENSAR, Inc. today announced that the Company’s first quarter 2022 financial results will be released before market open on Monday, May 9, 2022.

May 2, 2022
·
1 min read
Business

Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that it will report its first quarter 2022 financial results on Wednesday, May 4, 2022.

May 2, 2022
·
1 min read